Back to acquisitions

Company profile

Neurotech

Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.

Location
Cumberland, Rhode Island, United States
Website
neurotechpharmaceuticals.com

Funding

No round listed

This company does not appear in the current investment-round dataset.

Acquisition

Acquired by Alcon

Deal value
$550M
Announced
Oct 20, 2026